| Patents for C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924) |
|---|
| 11/29/2006 | EP1726952A1 Method of in vivo screening of therapeutic agent for memory/learning dysfunction by schizophrenia |
| 11/29/2006 | EP1725565A2 Fused heterotricyclic compounds as inhibitors of 17b-hydroxysteroid dehydrogenase 3 |
| 11/14/2006 | CA2128955C Tricyclic benzazepine vasopressin antagonists |
| 11/09/2006 | CA2605473A1 Process for preparing quetiapine and quetiapine fumarate |
| 11/08/2006 | EP1719768A1 Novel benzothiazepine and benzothiepine compounds |
| 11/08/2006 | EP1021190B1 Amid derivatives as growth hormone release promotors |
| 11/07/2006 | US7132416 Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibotory activity for the treatment hyperlipidaemia |
| 11/01/2006 | CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 10/31/2006 | CA2350560C Novel type condensed pyridazinone compounds |
| 10/26/2006 | WO2006113425A1 Process for preparing quetiapine fumarate |
| 10/26/2006 | WO2006036941A3 Specific kinase inhibitors |
| 10/26/2006 | US20060241096 Agent for preventing or treating organ functional disorders and organ dysfunction |
| 10/26/2006 | CA2603795A1 Process for preparing quetiapine fumarate |
| 10/24/2006 | US7125864 Benzothiazepine derivatives for the treatment of hyperlipidemia |
| 10/19/2006 | WO2005103041A3 Treatment of cns disorders using cns target modulators |
| 10/18/2006 | EP1423112B1 A combination of quetiapine and zolmitriptan |
| 10/17/2006 | US7122662 Tricyclic compound having spiro union |
| 10/11/2006 | CN1279044C Non-steroidal progesterone receptor modulators |
| 09/28/2006 | WO2006101496A1 Novel anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (ryr2) |
| 09/28/2006 | CA2601541A1 Novel anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (ryr2) |
| 09/21/2006 | WO2006097449A1 N-hydroxyamides omega-substituted with tricyclic groups as histone deacetylase inhibitors, their preparation and use in pharmaceutical formulations |
| 09/21/2006 | CA2600521A1 N-hydroxyamides omega-substituted with tricyclic groups as histone deacetylase inhibitors, their preparation and use in pharmaceutical formulations |
| 09/19/2006 | US7109233 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 09/14/2006 | WO2006094549A1 A PROCESS FOR THE PREPARATION OF AN 11-(4-SUBSTITUTED-I-PIPERAZINYL)DIBENZO[b,f][1,4]THIAZEPINE DERIVATIVE |
| 09/13/2006 | EP1406881B1 11-piperazinyldibenzo(b,f)(1,4)oxazepines and thiazepines as atypical antipsychotic agents having low affinity for the d2 receptor |
| 08/31/2006 | WO2006074940A3 Macrocyclic compounds and compositions useful as bace inhibitors |
| 08/31/2006 | US20060194966 N'-{2-amino-1-(3,5-difluorobenzyl)-3-[(3-; ethylbenzyl)oxy]propyl}-N,N-dipropylisophthalamide; beta-secretase inhibitors; halts or reduces production of A beta peptide from amyloid precursor proteins and reduces or eliminates the formation of beta-amyloid deposits in the brain |
| 08/30/2006 | EP1694658A1 Method for the production of a thiazolo [3,4,5-de] [4,1]benzothiazepine-type product |
| 08/24/2006 | WO2006004774A3 Laulimalide analogues as therapeutic agents |
| 08/24/2006 | US20060189594 Procedure for preparing a pharmaceutically active compound |
| 08/17/2006 | WO2006085096A1 Ligands for g-protein coupled receptors |
| 08/17/2006 | CA2597481A1 Ligands for g-protein coupled receptors |
| 08/09/2006 | CN1268618C 1,5-benzothiazepines compounds and its use as antilipemic agent |
| 08/03/2006 | US20060173178 Reducing 2-nitro-2'-carboxy-diphenylsulfide derivative in presence of hydrogen gas and reduction catalyst; subjecting 2-amino-2'-carboxy-diphenylsulfide derivative to dehydration-condensation to produce dibenzo[b,f][1,4]thiazepin-11-one compound |
| 08/03/2006 | CA2595885A1 Controlled release compositions comprising an antipsychotic agent |
| 08/02/2006 | CN1810792A Process for producing dibenzo thionitrogen tropilidine derivative |
| 07/27/2006 | WO2006077602A1 INDUSTRIAL PREPARATION OF 11-[4-{2-(2-HYDROXYETHOXY ETHYL}-1-PIPERAZINYL] DIBENZO [b,f]-1[1, 4] THIAZEPINE |
| 07/27/2006 | US20060166965 Atypical antipsychotic agents having low affinity for the D2 receptor |
| 07/26/2006 | EP1682521A1 Macrocyclic lactams and pharmaceutical use thereof |
| 07/20/2006 | WO2006074940A2 Macrocyclic compounds and compositions useful as bace inhibitors |
| 07/20/2006 | CA2590664A1 Macrocyclic compounds and compositions useful as bace inhibitors |
| 07/19/2006 | CN1264848C Pyrrolo[2,1-b] [1,3] benzothiazepines and their use for preparation of medicaments with antipsychotic activity |
| 07/18/2006 | US7078521 By reaction of pyrrolobenzothiazepin-9-one with amine to give the corresponding enamine, which is subsequently transformed into the final compound |
| 07/13/2006 | WO2005082873A3 1,4-benzothiazepans and derivatives thereof |
| 07/06/2006 | US20060149057 Method of purifying macrolides |
| 07/04/2006 | US7071331 Synthesis of quetiapine and pharmaceutically acceptable salts thereof |
| 06/29/2006 | US20060142565 Method of purifying tacrolimus |
| 06/29/2006 | US20060142564 Methods of preparing pimecrolimus |
| 06/29/2006 | US20060142264 Novel amide derivatives |
| 06/28/2006 | CN1261430C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 06/20/2006 | US7064121 benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals |
| 06/15/2006 | US20060128739 Solvent free amorphous rapamycin |
| 06/15/2006 | US20060128680 porosity; nanostructure |
| 06/14/2006 | EP1667965A2 Bridged macrocyclic module compositions |
| 06/08/2006 | US20060122168 Malonamide derivatives |
| 06/07/2006 | EP1664009A1 Preparation method for quetiapine |
| 06/07/2006 | EP1664007A1 Preparation of quetiapine |
| 06/07/2006 | EP0934065B1 Novel cryptophycin derivatives as anti-neoplastic agents |
| 06/01/2006 | WO2006056772A2 Salts of quetiapine |
| 06/01/2006 | WO2006056771A1 Phosphoric acid salt of quetiapine |
| 06/01/2006 | WO2006056696A2 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof |
| 05/31/2006 | EP1660469A1 Process for the preparation of 11-(1-piperazinyl)dibenzo 'b, f! '1 ,4!-thiazepine, an intermediate in the synthesis of the antipsychotic drug quetiapine |
| 05/31/2006 | EP1660468A2 Procedure for preparing 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl)-dibenzo[b,f][1,4]thiazepine |
| 05/30/2006 | US7053109 Aminediols for the treatment of Alzheimer's disease |
| 05/24/2006 | CN1777594A Synthesis of quetiapine and pharmaceutically acceptable salts thereof |
| 05/16/2006 | US7045621 Process for producing dibenzothiazepine derivatives |
| 05/11/2006 | US20060100164 11-N-[4-(4-Pyridin-3-yl-imidazol-1-yl)-butyl]-6-O-methyl-5-O-(3-dimethylamino-2-hydroxy-propoxy)-3-oxo-erythronolide A, 11,12-carbamate; functionalized macrolides; antiviral, antiprotozoal, anticancer and antigastrointestinal |
| 05/04/2006 | US20060094884 Benzothiazepine and benzothiepine derivatives |
| 04/27/2006 | US20060089346 Optionally fused aryl-substituted azepanones, oxazepanone or thiazepanones substituted with a dipeptide group, e.g., N2-[(3,5-difluorophenyl)acetyl]-N1-[(2R,3R)-2-(2,5-difluorophenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl]-L-alaninamide; secretase inhibitors for treating Alzheimer's disease |
| 04/06/2006 | CA2581375A1 Specific kinase inhibitors |
| 03/30/2006 | US20060069083 Pesticidal dibenzo(hetero)azepine derivatives |
| 03/29/2006 | EP1638946A2 2-aminoethyl substituted pyrimidin-2-ones, cyclopropanes, pyrazolines, pyrimidines and benzothiazepines and their use as urotensin ii urotensini ii and somatostatins 5 receptor ligands |
| 03/29/2006 | EP1638549A2 Novel antibacterial agents |
| 03/29/2006 | CN1247556C Process for producing dibenzothiazepine derivatives |
| 03/22/2006 | CN1751029A 2-aminoethyl substituted pyrimidin-2-ones, cyclopropanes, pyrazolines, pyrimidines and benzothiazepines and their use as urotensin ii and somatostatin 5 receptor ligands |
| 03/08/2006 | EP1632470A2 Calcium receptor active molecules |
| 03/07/2006 | US7008938 Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient |
| 02/23/2006 | CA2575979A1 Novel serotonin receptor ligands and their uses thereof |
| 02/01/2006 | CN1239497C Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide |
| 02/01/2006 | CN1239487C Internediate for preparing quetiapin and preparation method of the intermediate |
| 01/11/2006 | CN1235889C Cyanomethylene compounds, process for producing the same, and agricultural or horticultural bactericide |
| 01/05/2006 | WO2006001619A1 PROCESS FOR THE PREPARATION OF 11-(4-[2-(2-HYDROXYETHOXY)ETHYL]-I-PIPERAZINYL)DIB ENZO[b,f][l,4]THIAZEPINE |
| 01/05/2006 | US20060003978 beta-secretase inhibitors; to reduce A beta peptide formation; to reduce amyloid beta deposits or plaques; 12-[2-(3-Ethyl-benzylamino)-1-hydroxy-ethyl]-16-fluoro-2-oxa-8,11-diaza-bicyclo[12.3.1]octadeca-1(17),14(18),15-triene-7,10-dione |
| 12/22/2005 | WO2005103041A9 Treatment of cns disorders using cns target modulators |
| 12/07/2005 | EP1602650A1 Method for the preparation of quetiapine by reductive N-alkylation of 11-Piperazinodibenzo(B,F) (1,4)Thioazepin with an aldehyde |
| 11/23/2005 | EP1597245A1 Benzothiazepine and benzothiepine derivatives |
| 11/22/2005 | US6967197 Also used in production of tumor necrosis factor alpha |
| 11/16/2005 | EP0979227B1 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists |
| 11/10/2005 | WO2005105793A1 Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure |
| 11/10/2005 | CA2565024A1 Therapeutic agent for left ventricular diastolic dysfunction |
| 11/09/2005 | EP1593676A1 8-Chloro-11-(4-(2'-hydroxyethyl)piperazin-1-yl)-dibenzo[b,f][1,4]oxazepine of atypical anti-psychotic activity and having a low affinity for the dopamine D2 receptor |
| 11/03/2005 | WO2005103041A2 Treatment of cns disorders using cns target modulators |
| 11/03/2005 | CA2563826A1 Treatment of cns disorders using cns target modulators |
| 10/27/2005 | WO2005100366A1 Proline cci-779 (proline-rapamycin 42-ester with 2,2-bis (hydroxymethyl) propionic acid) and two-step enzymatic synthesis of proline cci-779 and cci-779 using microbial lipase |
| 10/27/2005 | CA2564811A1 Proline cci-779 (proline-rapamycin 42-ester with 2,2-bis (hydroxymethyl) propionic acid) and two-step enzymatic synthesis of proline cci-779 and cci-779 using microbial lipase |
| 10/26/2005 | EP1589008A1 A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent |
| 10/26/2005 | EP1246837B1 Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and the use thereof in the synthesis of synthetic proteins and polypeptides |
| 10/20/2005 | US20050234086 Proline CCI-779, production of and uses therefor, and two-step enzymatic synthesis of proline CCI-779 and CCI-779 |
| 10/20/2005 | US20050234038 Protease inhibitors |
| 10/13/2005 | WO2005095338A1 Alkoxyphenylpropanoic acid derivatives |